Prevalence of cardiovascular diseases in China

Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X. Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation, 2008, 118(25): 2679–2686

Mark D B, Van de Werf F J, Simes R J, White H D, Wallentin L C, Califf R M, Armstrong P W; VIGOUR Group for the VG. Cardiovascular disease on a global scale: defining the path forward for research and practice. Eur Heart J, 2007, 28(21): 2678–2684

Klein W. Cardiovascular disease at the turn of the millennium: focus on Europe. Eur Heart J Suppl, 2001, 3(Supplement M): M2–M6

Hua W, Zhang L F, Wu Y F, Liu X Q, Guo D S, Zhou H L, Gou Z P, Zhao L C, Niu H X, Chen K P, Mai J Z, Chu L N, Zhang S. Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol, 2009, 54(12): 1110–1118

Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001, 104(22): 2746–2753

He Y, Jiang B, Wang J, Feng K, Chang Q, Zhu S, Fan L, Li X, Hu F B. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. Diabetes Care, 2007, 30(8): 2128–2134

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen C S, Chen J, Wildman R P, Klag M J, Whelton P K. Major causes of death among men and women in China. N Engl J Med, 2005, 353(11): 1124–1134

Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton P K, He J. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension, 2004, 43(3): 578–585

Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation, 2004, 110(10): 1236–1244

Zhang X H, Lu Z L, Liu L. Coronary heart disease in China. Heart, 2008, 94(9): 1126–1131

Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation, 2001, 103(3): 462–468

Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser S H, Ehrlich J R. Changes in microRNA-1 expression and I(K1) upregulation in human atrial fibrillation. Heart Rhythm, 2009, 6(12): 1802–1809

Coronel R, Langerveld J, Boersma L V, Wever E F, Bon L, van Dessel P F, Linnenbank A C, van Gilst W H, Ernst S M, Opthof T, van Hemel N M. Left atrial pressure reduction for mitral stenosis reverses left atrial direction dependent conduction abnormalities. Cardiovasc Res, 2009, DOI: 10.1093/CVR/CVP374

Virtanen J K, Mursu J, Voutilainen S, Tuomainen T P. Serum longchain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation, 2009, 120(23): 2315–2321

Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol, 2008, 52(10): 865–868

Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol, 2008, 18(5): 209–216

He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton P K. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004, 110(4): 405–411

Zhang S. Atrial fibrillation in mainland China: epidemiology and current management. Heart, 2009, 95(13): 1052–1055

Pascual-Figal D A, Ordonez-Llanos J, Tornel P L, Vazquez R, Puig T, Valdes M, Cinca J, de Luna A B, Bayes-Genis A. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol, 2009, 54(23): 2174–2179

George A L Jr. Common genetic variants in sudden cardiac death. Heart Rhythm, 2009, 6(11 Suppl): S3–9

Colquhoun S M, Carapetis J R, Kado J H, Steer A C. Rheumatic heart disease and its control in the Pacific. Expert Rev Cardiovas Ther, 2009, 7(12): 1517–1524

Zhimin W, Yubao Z, Lei S, Xianliang Z, Wei Z, Li S, Hao W, Jianjun L, Detrano R, Rutai H. Prevalence of chronic rheumatic heart disease in Chinese adults. Int J Cardiol, 2006, 107(3): 356–359

Knirsch W, Zingg W, Bernet V, Balmer C, Dimitropoulos A, Pretre R, Bauersfeld U, Latal B. Determinants of body weight gain and association with neurodevelopmental outcome in infants operated for congenital heart disease. Interact Cardiovasc Thorac Surg, 2009, DOI: 10.1510/icvts.2009.216135

Yang X Y, Li X F, Lu X D, Liu Y L. Incidence of congenital heart disease in Beijing, China. Chin Med J (Engl), 2009, 122(10): 1128–1132

Callow A D. Cardiovascular disease 2005-the global picture. Vascul Pharmacol, 2006, 45(5): 302–307

Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds R F, Su S, Whelton P K, He J. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension, 2002, 40(6): 920–927

Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation, 2001, 104(23): 2855–2864

Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds R F, Whelton P K, He J. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation, 2005, 112(5): 658–665

Liu L. Cardiovascular diseases in China. Biochem Cell Biol, 2007, 85(2): 157–163

Cheng T O. The current state of cardiology in China. Int J Cardiol, 2004, 96(3): 425–439

Howard B V, Comuzzie A, Devereux R B, Ebbesson S O, Fabsitz R R, Howard W J, Laston S, Maccluer J W, Silverman A, Umans J G, Wang H, Weissman N J, Wenger C R. Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Nutr Metab Cardiovasc Dis, 2009, DOI: 10.1016/j

Liu M, Wu B, Wang W Z, Lee L M, Zhang S H, Kong L Z. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol, 2007, 6(5): 456–464

Berger J S, Bhatt D L, Steinhubl S R, Shao M, Steg P G, Montalescot G, Hacke W, Fox K A, Lincoff A M, Topol E J, Berger P B. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation, 2009, 120(23): 2337–2344

Hu J, Wallace D C, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nurs, 2009, 26(6): 500–511

Cheng T O. Smoking and diabetes in Chinese men. Postgrad Med J, 2001, 77(910): 551

Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds R F, Whelton P K, He J. Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health, 2004, 94(11): 1972–1976

McGuire K A, Janssen I, Ross R. Ability of physical activity to predict cardiovascular disease beyond commonly evaluated cardiometabolic risk factors. Am J Cardiol, 2009, 104(11): 1522–1526

Fu F H, Fung L. The cardiovascular health of residents in selected metropolitan cities in China. Prev Med, 2004, 38(4): 458–467

Kelly T N, Gu D, Chen J, Huang J F, Chen J C, Duan X, Wu X, Yau C L, Whelton P K, He J. Hypertension subtype and risk of cardiovascular disease in Chinese adults. Circulation, 2008, 118(15): 1558–1566

Lee D E, Cooper R S. Recommendations for global hypertension monitoring and prevention. Curr Hypertens Rep, 2009, 11(6): 444–449

Tang J L, Hu Y H. Drugs for preventing cardiovascular disease in China. BMJ, 2005, 330(7492): 610–611